 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 環(huán)保部標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G388550 |
| 產(chǎn)品名稱(chēng)：Giripladib |
| 產(chǎn)品CAS：865200-20-0 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G388550 |
| 名稱(chēng): |
Giripladib |
| 別名: |
4-[3-[5-Chloro-1-(diphenylmethyl)-2-[2-[[[[2-(trifluoromethyl)phenyl]methyl]sulfonyl]amino]ethyl]-1H-indol-3-yl]propyl]benzoic Acid; 4-(3-[5-Chloro-1-(diphenylmethyl)-2-[2-(((2-(trifluoromethyl)benzyl)sulfonyl)amino)ethyl]-1H-indole-3-yl]propyl)benzoic Acid; PLA 695 |
| CAS號(hào): |
865200-20-0 |
| 分子式: |
C??H??ClF?N?O?S |
| 分子量: |
745.25 |
| 種類(lèi): |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Giripladib inhibits cytosolic phospholipase A2 (cPLA2) which in turn radiosensitizes tumors in lung cancer animal models. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
